✨
AI Summary
- Lynelle Hoch discusses CAR-T's future and innovations.
- Focus on patient access progress in solid tumors and hematologic malignancies.
- Bristol Myers Squibb's cell therapy advancements were highlighted.
Guests on This Episode
LH
Lynelle Hoch
1 podcast appearance